Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines.
about
Antihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: a review of the evidenceEvaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistaminesDecongestant efficacy of desloratadine in patients with seasonal allergic rhinitis.Desloratadine in the treatment of chronic idiopathic urticaria.The pharmacologic profile of desloratadine: a review.Genetics of allergy and bronchial hyperresponsiveness.Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug.Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative study.Next generation antihistamines: therapeutic rationale, accomplishments and advances.Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells.Desloratadine: a nonsedating antihistamine.Rhinitis symptoms and quality of life in patients with chronic perennial rhinitis treated with desloratadine.Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosaSynergistic action of famotidine and chlorpheniramine on acetic acid-induced chronic gastric ulcer in rats.Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine.Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: Implications for anti-inflammatory activity of antihistamines.Cytokine elevation and transaminitis after laparoscopic donor nephrectomy.
P2860
Q28282236-36F5C4DF-98BE-403C-AE41-316EE38A22B1Q30447953-6F109389-6093-4FCC-ADA8-7DCF377069C8Q32175291-2A6293A7-82EC-41A9-AE86-553840CAD353Q32175657-A840E5AD-3ED1-41EC-850D-EB811667EB1BQ32175747-6E2DAB28-5EE1-46D9-A4A7-0AD24A637934Q33696804-21420E66-177B-4E8D-8779-080DB9C48427Q34292689-46AEEAE9-AC83-41CE-A3D0-81FF8AB0B182Q34431787-3494A4CF-ABCA-43F7-B1CB-0B819DF70385Q34660867-29B910D0-AEFD-4E37-A2FA-39CCCC78287CQ34668115-D5D25EE8-768D-4E21-8EE8-7E89D95C097DQ35054259-FBCB9259-5970-499B-994D-B5CA7805053DQ39332763-42730315-AB82-4D8D-9ED3-C84A7EFA78A5Q39707033-0573857D-CAAA-4ABF-BA03-1FC484B975C4Q42158743-D56B692B-5546-463E-B4DC-7818A6D6C260Q43759651-CFF47C97-6A6F-42D8-928B-45BE2602D79BQ51188715-CCFE73BD-7F41-4577-AF57-272E4D6B1B23Q53390513-2D968724-3D85-4403-94B5-93F4F3F9745A
P2860
Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Pharmacological modulation of ...... ast and basophilic cell lines.
@en
type
label
Pharmacological modulation of ...... ast and basophilic cell lines.
@en
prefLabel
Pharmacological modulation of ...... ast and basophilic cell lines.
@en
P2093
P2860
P1476
Pharmacological modulation of ...... ast and basophilic cell lines.
@en
P2093
B M Czarnetzki
S Krüger-Krasagakes
U Kiessling
P2860
P304
P356
10.1111/J.1600-0625.1995.TB00257.X
P433
P577
1995-08-01T00:00:00Z